Medicine, Rheumatology Division

Grants

Grants per year 1993 2002 2007 2008 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2027

• 1 Not started
• 78 Active
• 356 Finished

Grants per year

Search results

• Prot# LBSL02: A Phs 2, Mlti-Cntr, Dbl-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, & Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects w/Systemic Lupus Erythematosus (SLE)

  Ramsey-Goldman, R.

  Human Genome Sciences, Inc.

  11/14/03 → 8/21/10

  Project: Research project

• Prot# GL02-01: A Randomized, Double-Blind, Multi-Center, Placebo Controlled Study to Assess Prevention of Bone Loss by Treatment with Gl701 (Prestara?) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids

  Ramsey-Goldman, R.

  Genelabs Technologies, Inc.

  1/31/03 → 8/21/10

  Project: Research project

• Prot# 104RA205: An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination with Methotrexate to Subjects with Rheumatoid Arthritis Who Previously Participated in Study 104RA203

  Ruderman, E. M.

  PPD Development, Biogen Inc.

  9/5/07 → 9/5/10

  Project: Research project

• Prot# 102-21: An Open Label Study of the Efficacy and Safety of Re-Treatments with Rituximab (MabThera®/Rituxan®) in Patients with Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNFa Therapies

  Ruderman, E. M.

  Biogen Inc.

  6/23/04 → 9/9/10

  Project: Research project

• Prot# 13G01: A Phase 1 Dose Escalation Study of Repeat Intra-Articular Administration of tgAAC94, A Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis Subjects With and Without Concurrent TNF-alpha Antagonist

  Ruderman, E. M.

  Targeted Genetics Corporation

  1/23/06 → 9/9/10

  Project: Research project

• Prot# M02-518: A Phase III Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Subjects with Moderate to Severely Active Psoriatic Arthritis

  Ruderman, E. M.

  PPD Development, Abbott Laboratories

  5/7/03 → 9/10/10

  Project: Research project

• Prot# 20030236: A Phase 4, Open-Label, Single-Arm, Observational Study Evaluating The Effectiveness and Safety of Enbrel® (etanercept) 50mg Once Weekly in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (infliximab)

  Ruderman, E. M.

  Amgen, Inc.

  7/9/04 → 9/10/10

  Project: Research project

• Prot# 120-20: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis Who Have Had an Inadequeate Respo

  Ruderman, E. M.

  IDEC Pharmaceuticals Corporation

  5/6/03 → 9/10/10

  Project: Research project

• Prot# WA18063B: A Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Prllel Grp Stdy of the Sfty & Rdctn of Sgn & Symptms Drng Trtmnt w/ MRA vs Plcb, In Cmbntn w/ Trdtnl DMARD Thrpy in Ptnts w/ Mdrt to Svre Actv Rhumtd Arthrts & an indqt rspns to crrnt DMARD Thrpy

  Ruderman, E. M. & Schnitzer, T. J.

  Hoffman-La Roche, Inc.

  7/11/05 → 9/10/10

  Project: Research project

• Prot# 16.0023: Open-Label Extension Treatment with TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trial 016.0012

  Ruderman, E. M.

  Immunex Corporation

  12/4/00 → 9/10/10

  Project: Research project

• Prot# 016.0018: Open-Label Extension Treatment with TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trials

  Ruderman, E. M.

  Immunex Corporation

  12/4/00 → 9/11/10

  Project: Research project

• Prot# WA18062: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Reduction of Signs and Symptoms During Treatment with MRA vs. Placebo, in Combination with Methotrexate in Patients with Moderate to Sever

  Ruderman, E. M.

  Hoffman-La Roche, Inc.

  9/23/05 → 9/11/10

  Project: Research project

• Prot# IM101-031-016: A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Use Study to Evaluate the Safety and Tolerability of BMS-188667 Administered Intravenously to Subjects with Active RA with or without Medic

  Ruderman, E. M.

  Bristol-Myers Squibb Pharmaceutical Research Institute

  1/9/03 → 9/11/10

  Project: Research project

• Prot# M02-537: A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients with Moderate to Severely Active Psoriatic Arthritis

  Ruderman, E. M.

  PPD Development, Abbott Laboratories

  9/24/03 → 9/11/10

  Project: Research project

• Prot# 016.0034: Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1)

  Ruderman, E. M.

  Mapi USA, Inc., Immunex Corporation

  2/22/02 → 9/13/10

  Project: Research project

• Prot# 016.0040: Open-Label, Long-Term Extension Study of Etanercept in the Treatment of Patients with Ankylosing Spondylitis Who Participated in Protocol 016.0037

  Ruderman, E. M.

  Immunex Corporation

  7/1/02 → 9/13/10

  Project: Research project

• Maturation of IL-1B and IL-18 in Novel Macrophage Aggresomes

  Stehlik, C.

  National Institute of Allergy and Infectious Diseases

  6/5/09 → 9/30/10

  Project: Research project

• Maturation of IL-1beta and IL-18 in Novel Macrophage Aggresomes

  Stehlik, C.

  National Institute of Allergy and Infectious Diseases

  6/5/09 → 9/30/10

  Project: Research project

• Prot# U2971g: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II/III Study to Evaluate the Efficacy and Safety of Rituximab in Subjects with Moderate to Severe Systemic Lupus Erythematosus

  Ramsey-Goldman, R.

  PPD Development, Genentech, Inc.

  1/20/06 → 10/6/10

  Project: Research project

• Prot# IM101042: A Phse IIB, Mlt-Cntr, Rndmzd, Dbl-Blnd, Plcb-Cntrlld Stdy to Evlt the Effccy & Sfty of Abatacept vs. Plcb on A Bckgrnd of Orl Glucocorticosteroids in the Trtmnt of Sbjcts w/ Systmc Lupus Erythematosus & the Prvnton of Sbsqnt Lupus Flare

  Ruderman, E. M.

  Bristol-Myers Squibb Pharmaceutical Research Institute

  5/16/06 → 10/21/10

  Project: Research project

• Prot# WX17801: A Prospective, Rndmzd, Dbl-Blind, Active Cntrlld, Parallel Group, Multi-Center Trial to Assess the Efficacy & Safety of Mycophenolate Mofetil (MMF) in Inducing Response & Maintaining Remission in Sbjts w/Lupus Nephritis {ALMS}

  Ghossein, C. & Ramsey-Goldman, R.

  PPD Development, Aspreva Pharmaceuticals Corporation

  10/28/05 → 10/26/10

  Project: Research project

• Kirkland Scholar Award

  Ramsey-Goldman, R.

  Mary Kirkland Center for Lupus Research and Rheuminations, Inc.

  11/1/06 → 10/31/10

  Project: Research project

• Characterization of Regulatory CD8+ T Cells Returning in Refractory Lupus Patients Following Hematopoietic Stem Cell Transplantation

  Datta, S. K., Burt, R. K. & Zhang, L.

  Northwestern Memorial Foundation

  1/1/10 → 12/31/10

  Project: Research project

• TGF-beta and c-Abl: A Novel Pathway of Fibrosis

  Hinchcliff, M. E.

  Arthritis Foundation

  7/1/08 → 12/31/10

  Project: Research project

• 2006/2007/2008 Biomarkers Working Group Database/Collections Funding

  Ramsey-Goldman, R.

  Lupus Foundation of America, Inc.

  3/1/06 → 12/31/10

  Project: Research project